SESSION 1 - ANTIBODY-BASED DRUG DEVELOPMENT

Moderators: Luca Varani and Man Wah Tan
Keynote Speaker: Davide Corti, Humabs BioMed SA a subsidiary of Vir Biotechnology

André Frenzel, YUMAB, Germany
Andreas Laustsen, Technical University of Denmark, Denmark

SESSION 2 - NANOMEDICINE AGAINST INFECTIOUS DISEASES

Moderator: Luigi Calzolai

Donata Medaglini, University of Siena, Italy
Jennifer Grossman, National Institute of Health, USA

SESSION 3 - IMMUNOTHERAPY AGAINST EMERGING INFECTIOUS DISEASES

Moderators: Luca Varani and Larry Zetlin
Keynote Speaker: Antonio Lanzavecchia, IRB, Switzerland

Lisa Purcell, REGENERON, USA
Luca Varani, IRB, Switzerland
Jonas Fuener, Preclinics GmbH, Germany
Keynote Speaker: Man-Wah Tan, Genentech, USA
Selected abstracts for oral presentation

SESSION 4 - IMMUNOTHERAPY AGAINST VIRAL INFECTIONS

Moderators: Mireia Pelegrin and Antonio Lanzavecchia
Keynote Speaker: Hugo Mouquet, Institut Pasteur, France

Pongrama Ramasoota, Mahidol University, Bangkok, Thailand
Nancy Haigwood, Oregon National Primate Research Center, Oregon Health and Science University, USA
Fausto Baldanti, Policlinico San Matteo, IRCCS, Pavia, Italy
Keynote Speaker: Larry Zeitlin, Mapp Biopharmaceutical, USA
Selected abstracts for oral presentations
Poster Session

SESSION 5 - IMMUNOTHERAPY AGAINST BACTERIAL INFECTIONS

Moderators: Micheal Hust and Mireia Pelegrin

Theam Soon Lim, University SainsMalaysia (USM), Penang, Malaysia
Michael Hust, Technische Universität Braunschweig, Germany
Matteo Pizzuto, Humabs BioMed SA a subsidiary of Vir Biotechonolgy
Bernhard B. Singer, University Hospital Essen, Germany
Anna Codina, Bruker Biospin

SESSION 6 - PRODUCTION AND REGULATORY CHALLENGES

Moderator: Luigi Calzolai Marisa Papaluca, former senior scientist, European Medicinal Agency
Leander Grode, VPM GmbH, Hannover, Germany

SESSION 7 - 3RS PRINCIPLES IN BIOTECHNOLOGICAL AND MEDICAL APPLICATIONS

Moderator: Livia Visai Laura Gribaldo, Scientific Officer, European Commission Joint Research Centre, Italy
Jeff Brown, PETA International Science Institute, USA (3R and Infectious Disease)
Selected abstracts for oral presentation

TO BE DEFINED

CONCLUSIONS AND REMARKS